Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.
Saved in:
| Title: | Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients. |
|---|---|
| Authors: | Pearl, Meghan1 (AUTHOR) mpearl@mednet.ucla.edu, Weng, Patricia L.1 (AUTHOR), Chen, Lucia1 (AUTHOR), Dokras, Aditi1 (AUTHOR), Pizzo, Helen2 (AUTHOR), Garrison, Jonathan2 (AUTHOR), Butler, Carrie3 (AUTHOR), Zhang, Jennifer3 (AUTHOR), Reed, Elaine F3 (AUTHOR), Kim, Irene K.2 (AUTHOR), Choi, Jua2 (AUTHOR), Haas, Mark2 (AUTHOR), Zhang, Xiaohai2 (AUTHOR), Vo, Ashley2 (AUTHOR), Chambers, Eileen Tsai4 (AUTHOR), Ettenger, Robert1 (AUTHOR), Jordan, Stanley2 (AUTHOR), Puliyanda, Dechu2 (AUTHOR) |
| Source: | Clinical Transplantation. Aug2022, Vol. 36 Issue 8, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09020063 |
|---|---|
| DOI: | 10.1111/ctr.14734 |
